Ubs Group Ag Astrazeneca PLC Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Astrazeneca PLC stock. As of the latest transaction made, Ubs Group Ag holds 1,832,320 shares of AZN stock, worth $139 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,832,320

Previous 13,400 13574.03%

Holding current value

$139 Million

Previous $907,000 15655.46%

% of portfolio

0.04%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $4.28 Million - $5.18 Million	-64,050 Reduced 3.38%	1,832,320 $143 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $29.4 Million - $33.5 Million	-481,973 Reduced 20.27%	1,896,370 $128 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $26.1 Million - $29.2 Million	421,076 Added 21.51%	2,378,343 $160 Million
Q3 2023 Nov 09, 2023	BUY	$64.85 - $71.7 $11.1 Million - $12.3 Million	171,480 Added 9.6%	1,957,267 $133 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $20.4 Million - $22.1 Million	291,457 Added 19.5%	1,785,787 $128 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $3.7 Million - $4.19 Million	58,518 Added 4.08%	1,494,330 $104 Million
Q4 2022 Feb 08, 2023	BUY	$54.21 - $70.44 $16.2 Million - $21.1 Million	299,574 Added 26.37%	1,435,812 $97.3 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $7.65 Million - $19.6 Million	144,325 Added 14.55%	1,136,238 $62.3 Million
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $9.54 Million - $11.5 Million	-160,959 Reduced 13.96%	991,913 $65.5 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $9.79 Million - $11.8 Million	175,698 Added 17.98%	1,152,872 $76.5 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $827,100 - $977,301	-15,311 Reduced 1.54%	977,174 $56.9 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $5.06 Million - $5.54 Million	91,142 Added 10.11%	992,485 $59.6 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $1.67 Million - $2.07 Million	34,432 Added 3.97%	901,343 $54 Million
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $1.01 Million - $1.17 Million	-21,466 Reduced 2.42%	866,911 $43.1 Million
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $2.69 Million - $3.22 Million	55,457 Added 6.66%	888,377 $44.4 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $937,322 - $1.08 Million	-17,662 Reduced 2.08%	832,920 $45.6 Million
Q2 2020 Jul 31, 2020	SELL	$43.1 - $55.31 $2.88 Million - $3.7 Million	-66,932 Reduced 7.29%	850,582 $45 Million
Q1 2020 May 01, 2020	SELL	$37.79 - $51.33 $11.3 Million - $15.3 Million	-297,932 Reduced 24.51%	917,514 $41 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $2.13 Million - $2.54 Million	-50,255 Reduced 3.97%	1,215,446 $60.6 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $4.66 Million - $5.28 Million	-116,149 Reduced 8.41%	1,265,701 $56.4 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $20.4 Million - $22.8 Million	-545,990 Reduced 28.32%	1,381,850 $57 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $6.99 Million - $8.48 Million	-197,040 Reduced 9.27%	1,927,840 $77.9 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $9.35 Million - $10.5 Million	-253,790 Reduced 10.67%	2,124,880 $80.7 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $11.2 Million - $12.8 Million	-321,560 Reduced 11.91%	2,378,670 $94.1 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $4.83 Million - $5.17 Million	-139,676 Reduced 4.92%	2,700,230 $94.8 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $2.02 Million - $2.25 Million	-61,331 Reduced 2.11%	2,839,906 $99.3 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $8.51 Million - $9.22 Million	-265,221 Reduced 8.38%	2,901,237 $101 Million
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $3.05 Million - $3.58 Million	-105,432 Reduced 3.22%	3,166,458 $107 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-352,891 Reduced 9.74%	3,271,890 $112 Million
Q1 2017 Nov 14, 2017	BUY	N/A	3,624,781	3,624,781 $113 Million

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $236B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account